Fredun Pharmaceuticals Allots 2.71 Lakh Shares Upon Warrant Conversion
Fredun Pharmaceuticals Ltd 路 Others (Uncategorized) 路 17 Sept 2026, 2:22 am
Fredun Pharmaceuticals Allots 2.71 Lakh Shares Upon Warrant Conversion Fredun Pharmaceuticals approved the allotment of 2,71,200 equity shares (face value Rs. 10 each) to 10 non-promoter allottees on 16th Sep'26, following the conversion of 90,400 warrants allotted on 29th Dec'25. Adjusted for a 1:2 bonus issue, each warrant converted into three equity shares upon receipt of full consideration (original issue price: Rs. 1,250 per warrant). Key allottees include Alchemy Long Term Ventures Fund (72,000 shares) and Alchemy Capital Management (54,000 shares). Following this conversion, 37,600 warrants remain outstanding.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. 路 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 路 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. 路 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. 路 14 Nov 2026
- Intimation of Earnings Conference Call for the Quarter Q2 of FY27 路 16 Nov 2026
- Press Release 路 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. 路 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. 路 05 Nov 2026
